ClinicalTrials.Veeva

Menu

Tumor Growth Factors in Hepatocellular Carcinoma

K

Kaohsiung Medical University

Status

Completed

Conditions

Hepatocellular Carcinoma

Treatments

Biological: tumor growth factor concentration

Study type

Observational

Funder types

Other

Identifiers

NCT00764140
KMUH-IRB-960010

Details and patient eligibility

About

Malignant cells frequently produce many tumor growth factors to autocidal or endocrinal proliferate growth, metastasis,or angiogenesis about tumor cells. By studying tumor growth factors in hepatocellular carcinoma, one may know the tumor behavior, its relationship with clinical manifestation or invasion, and could be used as diagnostic or prognostic tools.This study aims to study the relationship between tumor growth factors in HCC ant its clinical relevance.

Full description

The clinical relevance of patients will be evaluated by the concentrations of tumor growth factors.

Enrollment

400 patients

Sex

All

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Histology proven HCC

Exclusion criteria

  • No definitely diagnosed tumor

Trial design

400 participants in 2 patient groups

2
Description:
Specific tumor growth factors (IGFs, its binding proteins,receptors; transforming growth factor alpha and beta 1 and epidermal growth factor) in the urine and serum will be measured in patients with hepatocellular carcinoma and healthy controls
1
Description:
Patients with hepatocellular carcinoma and Healthy controls
Treatment:
Biological: tumor growth factor concentration

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems